Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Monika, Jagiello"'
Autor:
Marika Trudnowska, Aleksandra Podwojcik, Monika Jagiello, Patryk Przybylski, Magdalena Mazur-Milecka, Lukasz Wrobel, Emilia Kaczmarczyk, Krzysztof Lukaszuk, Jacek Ruminski
Publikováno v:
HSI
Automation or even computer assistance of the popular infertility treatment method: ICSI (Intracytoplasmic Sperm Injection) would speed up the whole process and improve the control of the results. This paper introduces a preliminary research for auto
Publikováno v:
Acta biochimica Polonica. 57(1)
Drugs used in chemotherapy give undesirable side effects, e.g., cardiotoxicity, leucopenia, hair loss and others. Covalent binding of a drug with a carrier may change its biodistribution, elimination and/or rate of transformation in the organism. The
Autor:
Urszula Kanska, Adam Opolski, Monika Jagiello, Janusz Boratyński, Renata Budzynska, Joanna Wietrzyk, Dmitry Nevozhay
Publikováno v:
Oncology research. 16(9)
Conjugation of anticancer drugs with different carriers has been extensively studied recently as a potential method of obtaining improved drug forms. The conjugation often results in the increase of the therapeutic effect, alteration of a toxicity pr
Autor:
Dmitry, Nevozhay, Renata, Budzynska, Monika, Jagiello, Urszula, Kanska, Mohamed Salah, Omar, Adam, Opolski, Joanna, Wietrzyk, Janusz, Boratynski
Publikováno v:
Anticancer research. 26(3A)
Methotrexate (MTX) is widely used in the treatment of a number of oncological and hematological diseases. Due to its known limitations, MTX is often conjugated with different carriers to obtain amended forms of the drug. In this study, the potential
Autor:
Dmitry, Nevozhay, Renata, Budzynska, Urszula, Kanska, Monika, Jagiello, Mohamed Salah, Omar, Janusz, Boratynski, Adam, Opolski
Publikováno v:
Anticancer research. 26(2A)
Methotrexate (MTX) is widely utilized in the clinical treatment of many forms of cancer. However, the drug has a short plasma half-life and causes toxic effects on normal proliferating cells. Conjugation with carriers is a possible way to alter these
Autor:
Urszula, Kanska, Mohamed Salah, Omar, Renata, Budzynska, Dmitry, Nevozhay, Monika, Jagiello, Adam, Opolski, Janusz, Boratynski
Publikováno v:
Anticancer research. 25(3B)
The aim of the study was to compare the antileukemic activity of methotrexate (MTX) conjugates with native and glycated fibrinogen. We expected that conjugates based on glycated fibrinogen would reveal higher antileukemic activity because of decrease